<DOC>
	<DOCNO>NCT00617513</DOCNO>
	<brief_summary>The purpose study determine dose prucalopride safe effective patient chronic idiopathic constipation . Hypothesis : Prucalopride 1 2 mg safe effective treatment chronic idiopathic constipation whereas 0,5 mg suboptimal dose .</brief_summary>
	<brief_title>Efficacy Safety Study Prucalopride Treatment Chronic Constipation</brief_title>
	<detailed_description>This phase II trial parallel-group design , consist drug-free run-in phase ( phase 1 ) , follow placebo control double-blind phase ( phase 2 ) . Patients receive either R093877 0.5 mg o.d. , 1 mg o.d . 2 mg o.d . placebo period 4 week . Phase 1 run-in period 4 week duration , bowel habit document existence constipation confirm . At start period exist laxative medication withdrawn patient instructed change dietary habit , particular fibre intake trial . Patients enter double-blind phase constipation show present run-in period . If definition constipation meet 4 week run-in period , double-blind treatment start . Phase 2 double-blind , randomize , placebo-controlled phase , patient treat 4 week either 0.5 mg , 1 mg 2 mg R093877 placebo give daily ( one capsule take breakfast ) . Patients admit double blind treatment period randomly allocate one 4 treatment arm .</detailed_description>
	<mesh_term>Constipation</mesh_term>
	<criteria>Age 1870 year . History constipation i.e. , patient report occurrence TWO OR MORE follow criterion least 6 month selection visit : 1. two few spontaneous* bowel movement week . 2. lumpy ( scyballae ) and/or hard stool least quarter stool . 3. sensation incomplete evacuation follow least quarter stool . 4. strain defaecation least quarter time . *A bowel movement consider spontaneous precede intake laxative agent within period 12 hour . An amendment make change period 24 hour . Moreover , amendment state : `` Patients never open bowel spontaneously would consider constipate eligible enter doubleblind phase trial , whether mention criterion meet laxativa/enemas induced stool '' . Constipation cause disability ; patient 's occupational , social recreational activity govern his/her constipation effort attain relief . Normal electromyographic inhibition pattern external anal sphincter straining ( clinical and/or electromyographic and/or manometric evidence acceptable ) . Absence organic abnormality colon barium enema total colonoscopic examination . This criterion amend : `` If complaint constipation recent onset , i.e. , present 6 month 1 year , result colonoscopic examination perform within last 12 month need . If complaint constipation present one year , result endoscopic examination perform within past three year acceptable '' . Poor result laxative treatment diet counselling . Constipation functional , i.e. , idiopathic nature . Availability patient 's write informed consent . Patient available followup trial period determine protocol . Constipation think druginduced . Presence secondary cause constipation , instance : endocrine disorder , metabolic disorder , neurologic disorder . Congenital megacolon/megarectum . History previous abdominal surgery hysterectomy , surgery Meckel 's diverticle , appendicectomy , cholecystectomy , inguinal repair , splenectomy , nephrectomy fundoplication . Known suspect organic disorder large bowel , i.e. , obstruction , carcinoma inflammatory bowel disease . Active proctological condition think responsible constipation . Evidence nonrelaxing pelvic floor ( `` anismus '' ) main cause constipation . Clinically significant ECG abnormality . Known illness condition might interfere way adequate assessment drug study , severe cardiovascular lung disease , neurologic psychiatric disorder , alcoholism , cancer AIDS . Impaired renal function Presence serum amylase , serum glutamicoxaloacetic transaminase ( SGOT ) serum glutamicpyruvic transaminase ( SGPT ) concentration &gt; 2 time upper limit normal . Clinically significant abnormality blood chemistry , haematology urinalysis selection . Pregnancy wish become pregnant course study . Breast feeding . Investigational drug receive 30 day precede trial . Known use street drug e.g. , marijuana , cocaine etc . Unability unwillingness return require followup visit . Reliability physical state prevent proper evaluation drug trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>February 2008</verification_date>
</DOC>